Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 205, Issue 1, Pages 13-17Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20072665
Keywords
-
Categories
Funding
- MRC [G120/822] Funding Source: UKRI
- Medical Research Council [G120/822] Funding Source: researchfish
- Medical Research Council [G120/822] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
Ask authors/readers for more resources
There is an ever-increasing understanding of the mechanisms by which pathogens such as bacteria, viruses, and protozoa activate dendritic cells (DCs) to drive T helper type 1 (Th1) responses, but we know much less about how these cells elicit Th2 responses. This gap in our knowledge puts us at a distinct disadvantage in designing therapeutics for certain immune-mediated diseases. However, progress is being made with the identification of novel endogenous tissue factors that can enhance Th2 induction by DCs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available